Praxis Precision Medicines, Inc. (NASDAQ:PRAX) stock experienced a volatile trading session on Monday, after the company ...

Praxis Precision Medicines' vormatrigine shows promise in epilepsy with 56.3% seizure reduction. Click here to find out why I ...

RADIANT study with vormatrigine in focal onset seizure (FOS) patients over eight weeks demonstrated 56.3% median reduction in ...

Paper cited: Ji, G et al. “A generalized epilepsy network derived from brain abnormalities and deep brain stimulation” Nature Communications DOI: 10.1038/s41467-025-57392-7 ...

With generalized epilepsy, there isn't one part of the brain that surgeons can remove to stop seizures. Instead, people who don’t respond to treatment may opt for brain stimulation devices.

Turned out I had been living with idiopathic generalized epilepsy since day one. I was stunned. I couldn't fathom the fact that this had been lingering in my brain for the last 20 years.

The SANAD II generalized epilepsy study included 520 people with two or more generalized or unclassifiable seizures recruited from April 2013 to August 2016 and randomized 1:1 to either ...

People with generalized epilepsy who have seizures arising from both sides of the brain simultaneously, have a higher risk of obstructive sleep apnea (OSA) compared to patients who have focal ...

More frequent seizures during the menstrual cycle in women with genetic generalized epilepsy have been linked for the first time to drug-resistant epilepsy, when anti-seizure medications don't ...

Early results from the PERPRISE study showed high retention and seizure-freedom rates among adults with focal or idiopathic generalized epilepsy who received perampanel as add-on therapy.

Among 2,214 persons with epilepsy, 7.5% had MDD, and 4% had generalized anxiety disorder. Those on valproic acid had the highest rates of MDD, while those on topiramate had the highest rates of GAD.